Name: ENCLAI disease-surveillance platform disclosure scorecard
Creator: ENCLAI
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Compiled by the ENCLAI research team following a documented methodology · Editorial oversight: Dr Natalya Mathur, Founder · Data last updated: 2026-11-08 (UTC)

Platform scorecard: what six surveillance vendors publish

Five questions a buyer can answer before talking to anyone, asked of six disease surveillance platforms. Every answer below carries the page it came from, the HTTP status that page returned, and the date it was checked, so you can re-run the check yourself and get the same answer — or catch us being wrong.

Read this first. This scorecard is published by ENCLAI, and one of the six platforms on it — ENCLAI — is ours and is sold for money. That is a real conflict of interest and you should read every row with it in mind. The only thing that makes publishing our own row defensible is that every platform is scored by the identical automated procedure, from its own public pages, with no manual override available for any row including ours. We do not score quality, accuracy, or value. We score only what a vendor does or does not publish, because that is the part you can check without our help.

The scorecard

How each answer was produced

For each platform we fetched the vendor's own published sitemap, enumerated the pages they index, and looked for a page of each type. Where one was found we fetched it and recorded its HTTP status. A pricing page was additionally tested for the presence of a currency figure. Nothing behind a login, a sales contact or an accepted terms page was examined. Where a vendor's sitemap could not be fetched, every cell for that vendor is marked unverified and is not scored.

Where this method can be wrong, stated plainly.

A page we cannot find may still exist. “Not published” means “not discoverable from the index the vendor publishes, and not at any conventional path”. That is what a buyer can find, which is the question — but it is not proof of absence.
We do not log in, accept terms, or contact sales. Anything behind those is out of scope by design. The question is what you can learn before entering a sales funnel.
Bot protection is not absence. A page answering HTTP 403 or 429 is marked blocked and is not scored. GIDEON’s API page answered 200 during one run and 403 minutes later purely because we had made many requests.
No sitemap means no score. Where a vendor publishes no fetchable sitemap we mark cells unverified rather than zero. We compete with four of these six; a scorer that turned “we could not check” into “they do not have it” would flatter its author.
Publishing is not quality. A vendor who publishes nothing may have a far better product. This page measures disclosure, and nothing else.

Corrections

If a cell here is wrong — including if we have missed a page you publish — tell us and we will correct it and date the correction. Vendors named on this page may ask for a correction at any time and we will act on it. ENCLAI is not affiliated with, endorsed by or in partnership with any organisation named here; product and organisation names are used only to identify what is being compared, and all trademarks belong to their owners.

Correction, 2026-11-02: an earlier version of the comparison page stated that GIDEON’s pricing URLs returned HTTP 404. That was wrong. GIDEON publishes a pricing page at gideononline.com/plans/ which returns HTTP 200; it states no figure and directs the reader to book a demo. The corrected finding is “page exists, no figure”, which is what this scorecard now records.

Platform	Access model	Price published publicly	Terms or licence page public	API documented publicly	Data sources named publicly	Methodology published
ENCLAI (ours) Enclai LLC, Virginia, USA	Free tier + paid subscription	published enclai.net/pricing HTTP 200 · 2026-11-02	published enclai.net/terms HTTP 200 · 2026-11-02	published enclai.net/docs/api HTTP 200 · 2026-11-02	published enclai.net/sources HTTP 200 · 2026-11-02	published enclai.net/how-we-verify HTTP 200 · 2026-11-02
BlueDot BlueDot Inc., Toronto, Canada	Commercial, quote-only	not published	not published	not published	not published	not published
Airfinity Airfinity Ltd, London, UK	Commercial, quote-only	not published	not published	not published	not published	not published
GIDEON GIDEON Informatics, Inc., USA	Commercial, quote-only	page exists, no figure	published www.gideononline.com/api-license/ HTTP 200 · 2026-11-02	published www.gideononline.com/api HTTP 200 · 2026-11-02	not published	not published
ProMED-mail International Society for Infectious Diseases	Free tier + paid subscription	published promedmail.org/subscribe/ HTTP 200 · 2026-11-02	published promedmail.org/terms-conditions/ HTTP 200 · 2026-11-02	unverified	unverified	unverified
HealthMap Boston Children's Hospital	Free, public	not published	published www.healthmap.org/about/termsofuse HTTP 200 · 2026-11-02	not published	not published	not published

Platform scorecard: what six surveillance vendors publish

The scorecard

How each answer was produced

Corrections

The daily disease brief